A 32-week preterm infant with RDS is managed with mechanical ventilation and exogenous surfactant. The clinical team is counseling the parents on complications and long-term outcomes. All of the following are recognized complications or sequelae of RDS and its treatment EXCEPT:
A. Bronchopulmonary dysplasia (BPD) develops due to prolonged mechanical ventilation and oxygen toxicity
B. Retinopathy of prematurity (ROP) is prevented by maintaining SpO₂ in the range of 85–89%
C. Pulmonary hypoplasia is a direct consequence of severe RDS if untreated
D. Intraventricular hemorrhage (IVH) risk is increased in preterm infants with RDS due to fluctuations in cerebral blood flow
Explanation
Complications of RDS and Its Management
Bronchopulmonary Dysplasia (BPD)
Key Point
BPD is a chronic lung disease of prematurity resulting from:
Modern "gentle ventilation" strategies (permissive hypercapnia, synchronized ventilation, early CPAP) have reduced BPD incidence, but it remains a major morbidity in extremely preterm infants.
Pulmonary Hypoplasia
High-YieldNEET PG
Pulmonary hypoplasia is NOT a direct consequence of RDS itself. Rather, it is a pre-existing structural abnormality caused by:
Congenital diaphragmatic hernia
Severe oligohydramnios (Potter sequence)
Bilateral renal agenesis
Skeletal dysplasias
Warning
Do not confuse pulmonary hypoplasia (underdevelopment of lung tissue) with RDS (surfactant deficiency). However, a preterm infant with RDS may have coexisting pulmonary hypoplasia if there was intrauterine growth restriction or other developmental insult.
Retinopathy of Prematurity (ROP)
Key Point
ROP is a vasoproliferative disorder of the retina caused by abnormal vascularization in response to:
Hyperoxia (high SpO2, high PaO2)
Hypoxia (rebound vasoconstriction)
Fluctuating oxygen levels
Mnemonic: STOP-ROP — Supplemental Therapeutic Oxygen Prevention of ROP
Critical High-Yield: Current evidence-based SpO2 targets for preterm infants are:
90–95% in infants <32 weeks or <1500 g (SUPPORT, COT trials)
Maintaining SpO2 at 85–89% is TOO LOW and increases risk of:
Hypoxic episodes
Pulmonary hypertension
Increased mortality
Does NOT reliably prevent ROP
Clinical Pearl
The goal is to avoid both hyperoxia and hypoxia; tight SpO2 control (90–95%) with minimal fluctuation is optimal.
Intraventricular Hemorrhage (IVH)
High-YieldNEET PG
IVH is a major complication in preterm infants with RDS due to: